Suven Life Sciences

BSE : 530239 | NSE : SUVEN

Industry : Pharma Research | ISIN : INE495B01038 | FreeFloat : 18.65% | FnO : No | LotSize : N/A


Intellectual Capital (IC)-143.11
Net Worth (NW)5.35
Intrinsic Worth (IW)-137.76
Market Cap (MC)1,492.71
Economic Value Added-41.93
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)-103.88%
IC Gross Margin (EBITDA/IC)95.44%
IC Net Margin (NPT/IC)96.10%
Knowledge Turnover (Sales/IC)-0.07
Market to Intrinsic Value (MC/IW)-10.84

As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. -6.32Rs. 68.45
3 Feb 2023 ---- Rs. 59.35
-1.00     -1.68%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 62.29SellStrong Sell
KB > 50% : No50 DMA : Rs. 64.02
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
8.66
11.66
-22.07
-23.13
-23.36
-25.56
-25.75
Jun-20
C
1.43
3.96
-11.67
-12.73
-12.96
-10.49
-10.49
Sep-20
C
8.98
11.26
-15.32
-16.39
-16.65
-15.66
-15.66
Dec-20
C
1.51
3.14
-24.98
-26.12
-26.30
-24.39
-24.39
Mar-21
C
1.56
2.88
-20.26
-21.32
-21.57
-21.61
-21.61
Jun-21
C
2.01
6.56
-38.02
-39.06
-39.21
-39.21
-39.21
Sep-21
C
1.18
1.69
-27.11
-28.15
-28.30
-28.30
-28.30
Dec-21
C
4.43
4.57
-32.34
-33.56
-33.69
-33.69
-33.69
Mar-22
C
4.22
4.34
-19.60
-20.70
-20.80
-20.80
-20.80
Jun-22
C
3.54
3.98
-20.64
-22.22
-22.33
-16.33
-16.33
Sep-22
C
4.39
4.59
-21.49
-23.11
-23.18
-23.18
-23.18
Dec-22
C
3.00
5.21
-49.38
-51.05
-51.12
-51.12
-51.12
* C - Consolidated, S - Standalone